Treatment strategies for anemia of CKD by disease stage | Drug cost per defined daily dose ($) | Average dose per week | Treatment cost per patient per week ($) | Annual treatment cost per patient ($) |
---|---|---|---|---|
Stage III/IV short acting ESA (SC) | 14.25 | 4,186 IU | 59.65 | 3,101.83 |
Stage III/IV long acting ESA (SC) | 13.36 | 21 mcg | 62.05 | 3,226.59 |
Stage V short acting ESA (SC) | 14.25 | 8,033 IU | 114.47 | 5,952.45 |
Stage V long acting ESA (SC) | 13.36 | 27 mcg | 79.27 | 4,122.01 |
Stage V short acting ESA (IV) | 14.25 | 11,475 IU | 163.52 | 8,502.98 |
Stage V long acting ESA (IV) | 13.36 | 38 mcg | 113.71 | 5,912.84 |